Nobi

Nobi keeps residents safe and dignified while empowering senior living operators with actionable insights to provide the right care at the right time.

High-Level Overview

Nobi is a Belgian AgeTech company founded in 2018 that develops AI-powered smart lamps for elderly care, focusing on fall detection, prevention, and prediction[1][3][4][6]. Its core product is a ceiling-mounted lamp with optical sensors and AI that monitors seniors in care facilities like hospitals and senior living communities, alerting caregivers instantly while analyzing patterns in sleep, health, and activity for personalized care[1][3][6]. Serving residents, families, and operators, Nobi solves the critical problem of falls among aging populations—reducing falls by up to 51-84%, slashing response times from 68 minutes to 4 minutes (94% faster), and nearly eliminating "long-lie" incidents that raise mortality risk[3][4][6]. Recent €35M Series B funding in 2025 fuels US and UK expansion, building on proven traction in facilities[3][4].

Origin Story

Nobi emerged in 2018 in Antwerpen, Belgium, driven by the need to address frequent falls in elderly care, a pressing issue amid aging populations[1][4]. Founders, backed by leading AI experts, spent six years developing the technology, training it on over 250,000 real-life scenarios to achieve high accuracy in detection and prevention[3]. Early pivotal moments include pilots in care homes across nearly 3,000 resident days, demonstrating 84% fall reductions and perfect detection rates, which propelled adoption in Europe and attracted major investors like Angelini Ventures and Nexus NeuroTech Ventures in the €35M Series B[3][4][6].

Core Differentiators

Nobi stands out in eldercare tech through seamless, non-intrusive integration and proven AI efficacy:

• AI-Powered Precision: Detects falls in seconds with 100% accuracy to date, predicts risks via behavior patterns, and prevents them using smart lighting (e.g., auto-illuminating chairs) and real-time alerts; trained on 250,000+ scenarios for reliability[3][4][6].
• Privacy-First Design: Processes data locally in the lamp, avoiding cameras or wearables; blends aesthetically as a normal light while capturing insights on sleep/activity without invading dignity[1][3][6].
• Impact Metrics: Achieves 51-84% fall reductions, 94% faster responses, and post-fall analytics for scenario prevention; eliminates long-lies, directly lowering mortality risks[3][4][6].
• Operational Ease: Dashboard integrates effortlessly into care workflows, cutting reporting time from 60+ to 20 minutes and enabling proactive, personalized care[6].

Role in the Broader Tech Landscape

Nobi rides the AgeTech wave, targeting a global aging crisis where falls cause billions in costs and high morbidity, amplified by labor shortages in senior care[3][4]. Timing is ideal: post-2025 funding aligns with surging demand in the US/UK, where populations over 65 are projected to double, and AI advancements enable non-wearable monitoring over competitors like EchoCare or Vayyar[1][3]. Market tailwinds include regulatory pushes for elder safety and investor focus on digital health (e.g., Angelini Ventures' portfolio), positioning Nobi to influence standards by proving ROI through data-driven prevention[3][4]. It shapes the ecosystem by enabling operators to reduce staffing needs, attract residents/families with safety assurances, and inspire hybrid AI-lighting models in healthcare[6].

Quick Take & Future Outlook

Nobi's trajectory points to dominance in AgeTech, with €35M fueling home deployments and broader AI enhancements for predictive health analytics[3][4]. Trends like edge AI privacy regs and personalized senior living will accelerate growth, potentially expanding to hospitals and consumer markets. Its influence may evolve from facility disruptor to ecosystem enabler, partnering with insurers for fall-risk premiums while scaling globally—cementing AI lamps as the new standard in dignified, proactive eldercare, much like its origin vision of redefining everyday lights for life-saving impact.